Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Calponin 2 regulates ketogenesis to mitigate acute kidney injury
Yuan Gui, Zachary Palanza, Priya Gupta, Hanwen Li, Yuchen Pan, Yuanyuan Wang, Geneva Hargis, Donald L. Kreutzer, Yanlin Wang, Sheldon I. Bastacky, Yansheng Liu, Silvia Liu, Dong Zhou
Yuan Gui, Zachary Palanza, Priya Gupta, Hanwen Li, Yuchen Pan, Yuanyuan Wang, Geneva Hargis, Donald L. Kreutzer, Yanlin Wang, Sheldon I. Bastacky, Yansheng Liu, Silvia Liu, Dong Zhou
View: Text | PDF
Research Article Nephrology

Calponin 2 regulates ketogenesis to mitigate acute kidney injury

  • Text
  • PDF
Abstract

Calponin 2 (CNN2) is a prominent actin stabilizer. It regulates fatty acid oxidation (FAO) by interacting with estrogen receptor 2 (ESR2) to determine kidney fibrosis. However, whether CNN2 is actively involved in acute kidney injury (AKI) remains unclear. Here, we report that CNN2 was induced in human and animal kidneys after AKI. Knockdown of CNN2 preserved kidney function, mitigated tubular cell death and inflammation, and promoted cell proliferation. Distinct from kidney fibrosis, proteomics showed that the key elements in the FAO pathway had few changes during AKI, but we identified that 3-hydroxymethylglutaryl-CoA synthase 2 (Hmgcs2), a rate-limiting enzyme of endogenous ketogenesis that promotes cell self-renewal, was markedly increased in CNN2-knockdown kidneys. The production of ketone body β-hydroxybutyrate and ATP was increased in CNN2-knockdown mice. Mechanistically, CNN2 interacted with ESR2 to negatively regulate the activities of mitochondrial sirtuin 5. Activated sirtuin 5 subsequently desuccinylated Hmgcs2 to produce energy for mitigating AKI. Understanding CNN2-mediated discrete fine-tuning of protein posttranslational modification is critical to optimize organ performance after AKI.

Authors

Yuan Gui, Zachary Palanza, Priya Gupta, Hanwen Li, Yuchen Pan, Yuanyuan Wang, Geneva Hargis, Donald L. Kreutzer, Yanlin Wang, Sheldon I. Bastacky, Yansheng Liu, Silvia Liu, Dong Zhou

×

Figure 4

Global proteomics reveals CNN2 knockdown increases Hmgcs2-mediated ketogenesis after AKI.

Options: View larger image (or click on image) Download as PowerPoint
Global proteomics reveals CNN2 knockdown increases Hmgcs2-mediated ketog...
After IRI at 1 day, (A) principal component analysis of global proteomes from ShNC and ShCNN2 kidneys. (B) Heatmap of t test significant proteins. Two clusters of proteins with different patterns of abundance profiles are highlighted. (C) Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis highlighted upregulated pathways in ShNC and ShCNN2 mouse kidneys. (D) Gene Ontology (GO) biological process terms in each cluster of proteins are plotted with their names and significance. (E) Heatmap of the key components in the fatty acid oxidation pathway in ShNC and ShCNN2 mouse kidneys. (F) Volcano plot showed the differential proteins between ShNC and ShCNN2 kidneys. Up- and downregulated proteins (fold-change, FC) are colored in yellow and blue, respectively. (G) Quantitative real-time PCR revealed Hmgcs2 mRNA levels in ShNC and ShCNN2 mouse kidneys. *P < 0.05 (n = 6). (H) Western blot assay demonstrated Hmgcs2 levels in ShNC and ShCNN2 mouse kidneys. (I and J) Immunohistochemical staining (I) showed Hmgcs2 expression in ShNC and ShCNN2 mouse kidneys. Costaining for Hmgcs2 (red) and aquaporin 1 (AQP1, green) in the kidneys (J, upper panel). Immunohistochemical staining showed Hmgcs2 expression in the kidney biopsy specimens from patients with AKI (J, lower panel). Scale bar, 50 µm. Arrows indicate positive staining. (K–M) ELISA showed the levels of β-OHB in blood (K), ATP in total kidney tissue (L), and alanine transaminase (ALT) in blood (M) from ShNC and ShCNN2 mice. *P < 0.05 (n = 7). (N) Western blot assay demonstrated the expression of Hmgcs2 protein in the liver from ShNC and ShCNN2 mice. For Western blot panels, numbers indicate individual animals within each group. Graphs are presented as means ± SEM. Differences between groups were analyzed using unpaired t tests or ANOVA followed by the Student-Newman-Keuls test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts